· · BrusselsLanguage:NLFREN
Brief

Record Funds Raised by KickCancer Run

Record Funds Raised by KickCancer Run

The ninth edition of the KickCancer Run, 'Run to Kick', has raised over 2.5 million euros for childhood cancer research, according to Bruzz. This record sum highlights societal engagement and the crucial need for funding in the fight against pediatric oncological conditions in Belgium.

5/10/2026, 00:08:35 · Redacteur EU-affaires

Full article

The KickCancer Run, also known as 'Run to Kick', has raised a record amount exceeding 2.5 million euros for childhood cancer research during its ninth edition. This was reported by the Brussels news outlet Bruzz on September 27, praising the KickCancer foundation's successful fundraising efforts. This result surpasses previous editions and confirms the growing support for the fight against pediatric oncological diseases in Belgium.

What is Happening

On September 27, Bruzz reported on the record proceeds from the Run to Kick, stating a sum greater than 2.5 million euros. While the exact total and a comparison with previous editions were not specified in the available source information, Bruzz qualifies the outcome as a record. This indicates a significant increase in fundraising compared to prior years, which is a positive sign for financing scientific research into childhood cancer.

Impact of Fundraising

The collected amount is exclusively dedicated to childhood cancer research. The KickCancer foundation plays a crucial role in raising funds and allocating them to promising research projects. Although specific projects or beneficiary institutions, such as universities or hospitals, are not mentioned in the source, such funding contributes to the development of innovative treatments and an improved quality of life for young patients. National collaboration between academic centers and specialized hospitals, such as Ghent University Hospital or UMC Sint-Pieter in Brussels, is essential for the effective deployment of these resources.

Background

KickCancer organizes the 'Run to Kick' as its primary fundraising campaign. This annual running event mobilizes thousands of participants and volunteers, and over nine editions, it has evolved into one of the most important initiatives in Belgium supporting childhood cancer research. Childhood cancer remains one of the leading causes of death by disease among children and adolescents in Belgium and worldwide. The need for specialized research is therefore consistently high.

"KickCancer's fundraising is designated for childhood cancer research." — Bruzz

Role of Foundations and Society

The efforts of foundations like KickCancer complement public funding, for example, from the Federal Public Service Health, Food Chain Safety and Environment. They fill research gaps that cannot always be covered by government budgets and often focus on specific, innovative projects. The involvement of the general public in events like the Run to Kick demonstrates broad societal awareness and a willingness to contribute to urgent health challenges. Collaboration with local authorities, such as the City of Brussels for event logistics, is also of great importance in this regard.

What This Means for Belgium

This record amount raised by the KickCancer Run holds significant value for the Belgian scientific landscape and healthcare sector. It enables researchers to delve deeper into the complex challenges of childhood cancer. This could lead to the discovery of new therapies and diagnostic methods, ultimately improving survival rates and quality of life for Belgian children with cancer.

Future Prospects and Collaboration

Continuous funding through initiatives like KickCancer is crucial for Belgian research groups focused on pediatric oncology. These groups often collaborate with international consortia and also receive support from bodies such as the Research Foundation - Flanders (FWO) and the Fonds National de la Recherche Scientifique (FNRS) in Wallonia. The successes in fundraising contribute to Belgium's reputation as a hub for medical innovation and encourage further investment in healthcare. The proceeds from this edition can further stimulate the development of studies at institutions like the Jules Bordet Institute or KU Leuven, thus contributing to a better future for all involved in childhood cancer.

Bronnen

Drafted with AI assistance from the sources above and automatically reviewed before publication. Our method

Related